Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Department of Radiation Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
J Appl Clin Med Phys. 2024 Nov;25(11):e14498. doi: 10.1002/acm2.14498. Epub 2024 Aug 27.
Bolus materials have been used for decades in radiotherapy. Most frequently, these materials are utilized to bring dose closer to the skin surface to cover superficial targets optimally. While cavity filling, such as nasal cavities, is desirable, traditional commercial bolus is lacking, requiring other solutions. Recently, investigators have worked on utilizing 3D printing technology, including commercially available solutions, which can overcome some challenges with traditional bolus.
To utilize failure modes and effects analysis (FMEA) to successfully implement a comprehensive 3D printed bolus solution to replace commercial bolus in our clinic using a series of open-source (or free) software products.
3D printed molds for bespoke bolus were created by exporting the DICOM structures of the bolus designed in the treatment planning system and manipulated to create a multipart mold for 3D printing. A silicone (Ecoflex 00-30) mixture is poured into the mold and cured to form the bolus. Molds for sheet bolus of five thicknesses were also created. A comprehensive FMEA was performed to guide workflow adjustments and QA steps.
The process map identified 39 and 30 distinct steps for the bespoke and flat sheet bolus workflows, respectively. The corresponding FMEA highlighted 119 and 86 failure modes, with 69 shared between the processes. Misunderstanding of plan intent was a potential cause for most of the highest-scoring failure modes, indicating that physics and dosimetry involvement early in the process is paramount.
FMEA informed the design and implementation of QA steps to guarantee a safe and high-quality comprehensive implementation of silicone bolus from 3D printed molds. This approach allows for greater adaptability not afforded by traditional bolus, as well as potential dissemination to other clinics due to the open-source nature of the workflow.
几十年来,团注材料一直被用于放射治疗。最常见的是,这些材料被用于将剂量靠近皮肤表面,以最佳地覆盖浅表靶区。虽然腔填充,如鼻腔,是理想的,但传统的商业团注材料缺乏,需要其他解决方案。最近,研究人员已经致力于利用 3D 打印技术,包括商业上可用的解决方案,这些解决方案可以克服传统团注材料的一些挑战。
利用失效模式和影响分析(FMEA)成功实施全面的 3D 打印团注解决方案,以一系列开源(或免费)软件产品替代我们临床使用的商业团注材料。
通过将治疗计划系统中设计的团注的 DICOM 结构导出并进行操作,为定制团注创建 3D 打印模具,以创建用于 3D 打印的多部件模具。将硅酮(Ecoflex 00-30)混合物倒入模具中并固化以形成团注。还为五种厚度的片状团注制作了模具。进行了全面的 FMEA,以指导工作流程调整和 QA 步骤。
流程图分别确定了定制和片状团注工作流程的 39 个和 30 个不同步骤。相应的 FMEA 突出显示了 119 个和 86 个失效模式,其中 69 个失效模式在两个过程中共享。对计划意图的误解是大多数得分最高的失效模式的潜在原因,这表明在过程早期涉及物理和剂量学至关重要。
FMEA 为设计和实施 QA 步骤提供了信息,以保证从 3D 打印模具安全、高质量地全面实施硅酮团注。这种方法允许更大的适应性,而不是传统团注所允许的,并且由于工作流程的开源性质,有可能传播到其他诊所。